Alcon AG traded at 58.80 this Friday August 21st, decreasing 0.48 or 0.81 percent since the previous trading session. Looking back, over the last four weeks, Alcon AG lost 7.10 percent. Over the last 12 months, its price fell by 10.64 percent. Looking ahead, we forecast Alcon AG to be priced at 57.62 by the end of this quarter and at 54.21 in one year, according to Trading Economics global macro models projections and analysts expectations.
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.